Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

102 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Alu-mediated phylogenetic novelties in gene regulation and development.
Hamdi HK, Nishio H, Tavis J, Zielinski R, Dugaiczyk A. Hamdi HK, et al. J Mol Biol. 2000 Jun 16;299(4):931-9. doi: 10.1006/jmbi.2000.3795. J Mol Biol. 2000. PMID: 10843848
Alu DNA polymorphism in ACE gene is protective for age-related macular degeneration.
Hamdi HK, Reznik J, Castellon R, Atilano SR, Ong JM, Udar N, Tavis JH, Aoki AM, Nesburn AB, Boyer DS, Small KW, Brown DJ, Kenney MC. Hamdi HK, et al. Biochem Biophys Res Commun. 2002 Jul 19;295(3):668-72. doi: 10.1016/s0006-291x(02)00728-3. Biochem Biophys Res Commun. 2002. PMID: 12099691
Discovery and optimization of benzenesulfonamides-based hepatitis B virus capsid modulators via contemporary medicinal chemistry strategies.
Ren Y, Ma Y, Cherukupalli S, Tavis JE, Menéndez-Arias L, Liu X, Zhan P. Ren Y, et al. Among authors: tavis je. Eur J Med Chem. 2020 Aug 5;206:112714. doi: 10.1016/j.ejmech.2020.112714. Online ahead of print. Eur J Med Chem. 2020. PMID: 32949990 Review.
Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV.
Mosa AI, AbouHaidar MG, Urbanowicz RA, Tavis JE, Ball JK, Feld JJ. Mosa AI, et al. Among authors: tavis je. Virol J. 2020 Sep 18;17(1):140. doi: 10.1186/s12985-020-01408-9. Virol J. 2020. PMID: 32948191
A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice.
Mosa AI, Urbanowicz RA, AbouHaidar MG, Tavis JE, Ball JK, Feld JJ. Mosa AI, et al. Among authors: tavis je. Vaccine. 2020 Sep 5:S0264-410X(20)31118-X. doi: 10.1016/j.vaccine.2020.08.066. Online ahead of print. Vaccine. 2020. PMID: 32900542
Diversity of the hepatitis C virus NS5B gene during HIV co-infection.
Ngwaga T, Kong L, Lin D, Schoborg C, Taylor LE, Mayer KH, Klein RS, Celentano DD, Sobel JD, Jamieson DJ, King CC, Tavis JE, Blackard JT. Ngwaga T, et al. Among authors: tavis je. PLoS One. 2020 Aug 4;15(8):e0237162. doi: 10.1371/journal.pone.0237162. eCollection 2020. PLoS One. 2020. PMID: 32750098 Free PMC article.
HBV replication inhibitors.
Pierra Rouviere C, Dousson CB, Tavis JE. Pierra Rouviere C, et al. Among authors: tavis je. Antiviral Res. 2020 Jul;179:104815. doi: 10.1016/j.antiviral.2020.104815. Epub 2020 May 5. Antiviral Res. 2020. PMID: 32380149 Review.
Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication.
Li Q, Lomonosova E, Donlin MJ, Cao F, O'Dea A, Milleson B, Berkowitz AJ, Baucom JC, Stasiak JP, Schiavone DV, Abdelmessih RG, Lyubimova A, Fraboni AJ, Bejcek LP, Villa JA, Gallicchio E, Murelli RP, Tavis JE. Li Q, et al. Among authors: tavis je. Antiviral Res. 2020 May;177:104777. doi: 10.1016/j.antiviral.2020.104777. Epub 2020 Mar 23. Antiviral Res. 2020. PMID: 32217151
Shedding light on RNaseH: a promising target for hepatitis B virus (HBV).
Edwards TC, Ponzar NL, Tavis JE. Edwards TC, et al. Among authors: tavis je. Expert Opin Ther Targets. 2019 Jul;23(7):559-563. doi: 10.1080/14728222.2019.1619697. Epub 2019 May 22. Expert Opin Ther Targets. 2019. PMID: 31084514 Free PMC article. No abstract available.
102 results
Jump to page
Feedback